Fact based stock researchLanhai Medical Investment (SHSE:600896)

Lanhai Medical Investment stock research in summary

Lanhai Medical Investment shares are more expensive than other comparable stocks. They are riskily financed, are poor value, and show below average growth. We recommend evaluating whether the future of the company Lanhai Medical Investment is really as positive as the high price of the shares suggests. If you come to the conclusion that the future for this company is only average, that could be a reason to sell this share.

Research History: Lanhai Medical Investment

Last update of Combined Rank: 17-May-2019. Financial reporting date used for calculating ranks: 31-Dec-2018. Stock research history is based on the Obermatt Method. The higher the rank, the better Lanhai Medical Investment is in the corresponding investment strategy.

Last update of Value Rank: 16-Aug-2019. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Lanhai Medical Investment; except for dividend yield where the rank is higher, the higher the yield.